astragaloside a has been researched along with 1-methyltryptophan in 1 studies
| Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) | Studies (1-methyltryptophan) | Trials (1-methyltryptophan) | Recent Studies (post-2010) (1-methyltryptophan) |
|---|---|---|---|---|---|
| 675 | 5 | 573 | 145 | 4 | 121 |
| Protein | Taxonomy | astragaloside a (IC50) | 1-methyltryptophan (IC50) |
|---|---|---|---|
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 5.039 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Le, V; Lin, S; Liu, J; Que, Z; Tian, J; Zhang, A; Zhang, L; Zheng, Y | 1 |
1 other study(ies) available for astragaloside a and 1-methyltryptophan
| Article | Year |
|---|---|
Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Coculture Techniques; Disease Progression; Drug Screening Assays, Antitumor; Female; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice, Inbred C57BL; Neoplasm Transplantation; Paclitaxel; Saponins; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Triterpenes; Tryptophan; Tumor Burden; Tumor Escape | 2014 |